Dyno Nobel (DNL) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
8 Jul, 2026Strategic update and transaction status
Negotiations for the sale of the fertilizer business to PT Pupuk Kalimantan Timur have ended due to value and timing risks, with no active negotiations underway.
Focus has shifted to capital management and a share buyback, while structural separation of Dyno Nobel and the fertilizer business remains a strategic priority, though a demerger is not being pursued.
Management teams are now largely dedicated to their respective businesses, with minimal overlap.
The company remains open to future opportunities to maximize value for the fertilizer business and will continue to assess options for structural separation.
Capital management and buyback
Announced commencement of an on-market share buyback program of up to AUD 900 million, prioritizing shareholder returns.
Buyback is enabled by the conclusion of the sale process and is consistent with prior commitments following the Waggaman transaction.
Balance sheet will be managed to maintain investment grade and net debt/EBITDA at 1.5x.
Capital allocation will prioritize the buyback, with organic growth initiatives for Dyno Nobel also supported.
Inorganic growth opportunities will be considered only after the buyback and transformation project are executed.
Operational and financial outlook
Fiscal year 2024 earnings outlook remains in line with previous half-year statements.
Fertilizer distribution business continues to improve margins and market share; full-year production volumes expected at the lower end of guidance.
Phosphate Hill plant is profitable at current spot DAP and gas prices, with gas cost position improved by AUD 30 million year-on-year.
Sulfuric acid supply for Phosphate Hill is secured through 2030, unaffected by Glencore closures.
Dyno Nobel business performance remains consistent and strong, as previously reported.
Latest events from Dyno Nobel
- Transformation strategy targets doubling EBIT, global growth, and disciplined capital returns.DNL
Investor Showcase 20248 Jul 2026 - Record underlying EBIT growth and transformation offset statutory loss from impairments.DNL
H2 20248 Jul 2026 - Transformation and asset sales drive return to profit and strong 2H outlook.DNL
H1 20258 Jun 2026 - FY25 EBIT ex IMIs up 23%, $579m asset sale cash, $1.4bn capital return, FY26 EBIT $460m–$500m.DNL
H2 20258 Jun 2026 - EBIT up 39% and NPAT ex IMIs up 83% YoY; FY26 EBIT guidance and buyback progress reaffirmed.DNL
H1 20268 Jun 2026 - Strong financial results, strategic transformation, and robust shareholder support defined the AGM.DNL
AGM 20253 Feb 2026